Literature DB >> 17987884

Update on ovarian hyperstimulation syndrome: Part 1--Incidence and pathogenesis.

Helge Binder1, Ralf Dittrich, Friedrich Einhaus, Jürgen Krieg, Andreas Müller, Richard Strauss, Matthias W Beckmann, Susanne Cupisti.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a rare and potentially life-threatening complication during controlled ovarian stimulation. It can be associated with severe morbidity and may even be fatal. The etiology of the condition and predisposing factors are still not fully understood. Data concerning pathophysiology in patients with OHSS were searched using PubMed and other medical data bases. The incidence of severe OHSS, as calculated by World Health Organization (WHO), is 0.2-1% of all stimulation cycles in assisted reproduction. Considerations on OHSS classifications and forms of manifestations are discussed in detail. New insights concerning genetics and altered FSH receptor are given. OHSS may involve, according to its grade of severity, elevated or decreased levels of growth factors, cytokines, mediators, changes in hormones, renin-angiotensin and kinin-kallikrein system. There are massive electrolytic imbalances and changes in hemodynamic and fluid metabolism. Furthermore, liver and pulmonary dysfunction is observed as well as increased coagulation with subsequent thromboembolism. The influence of OHSS on the pregnancy rate and outcome of pregnancy is a matter of controversy. Patients with OHSS have high pregnancy rates with a tendency to an increased incidence of abortion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17987884

Source DB:  PubMed          Journal:  Int J Fertil Womens Med        ISSN: 1534-892X


  18 in total

1.  Rare genetic variants suggest dysregulation of signaling pathways in low- and high-risk patients developing severe ovarian hyperstimulation syndrome.

Authors:  L Borgwardt; K W Olsen; M Rossing; R Borup Helweg-Larsen; M Toftager; A Pinborg; J Bogstad; K Løssl; A Zedeler; M L Grøndahl
Journal:  J Assist Reprod Genet       Date:  2020-09-18       Impact factor: 3.412

2.  Failure of fertility therapy and subsequent adverse cardiovascular events.

Authors:  Jacob A Udell; Hong Lu; Donald A Redelmeier
Journal:  CMAJ       Date:  2017-03-13       Impact factor: 8.262

3.  Sudden death of an egg donor during oocyte retrieval due to ovarian hyperstimulation syndrome.

Authors:  Swati Tyagi; Asit Ranjan Mridha; Chittaranjan Behera
Journal:  Autops Case Rep       Date:  2022-05-27

Review 4.  The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.

Authors:  Lisa C Grossman; Konstantinos G Michalakis; Hyacinth Browne; Mark D Payson; James H Segars
Journal:  Fertil Steril       Date:  2010-09       Impact factor: 7.329

5.  Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles.

Authors:  Srisailesh Vitthala; Jerome Bouaziz; Amanda Tozer; Ariel Zosmer; Talha Al-Shawaf
Journal:  Int J Endocrinol       Date:  2012-02-12       Impact factor: 3.257

6.  Molecular analysis of a mutated FSH receptor detected in a patient with spontaneous ovarian hyperstimulation syndrome.

Authors:  Sayaka Uchida; Hiroshi Uchida; Tetsuo Maruyama; Takashi Kajitani; Hideyuki Oda; Kaoru Miyazaki; Maki Kagami; Yasunori Yoshimura
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

7.  Severe ovarian hyperstimulation syndrome: Can we eliminate it through a multipronged approach?

Authors:  Nikita Naredi; S K Singh; Prasad Lele; N Nagraj
Journal:  Med J Armed Forces India       Date:  2017-06-19

Review 8.  Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention.

Authors:  Petal Elder; Garima Sharma; Martha Gulati; Erin D Michos
Journal:  Am J Prev Cardiol       Date:  2020-06-06

9.  Ovarian hyperstimulation syndrome and prophylactic human embryo cryopreservation: analysis of reproductive outcome following thawed embryo transfer.

Authors:  Eric Scott Sills; Laura J McLoughlin; Marc G Genton; David J Walsh; Graham D Coull; Anthony P H Walsh
Journal:  J Ovarian Res       Date:  2008-11-06       Impact factor: 4.234

Review 10.  Discovery and Development of Small Molecule Allosteric Modulators of Glycoprotein Hormone Receptors.

Authors:  Selvaraj G Nataraja; Henry N Yu; Stephen S Palmer
Journal:  Front Endocrinol (Lausanne)       Date:  2015-09-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.